Activities of daily living and health status benefits of semaglutide in very old patients with heart failure, type 2 diabetes, and obesity: Real-world practice study
Medicina clinica · 2026 Oct 30 · Pérez-Velasco MA, Trenas A, Padilla-Leiva C et
MH
By Maren Holt · Senior Reporter, GLP-1
Oct 29 20:00 ETSource: Medicina clinica
From the source
Read at pubmed.ncbi.nlm.nih.govActivities of daily living and health status benefits of semaglutide in very old patients with heart failure, type 2 diabetes, and obesity: Real-world practice study
Medicina clinica · 2026 Oct 30 · Pérez-Velasco MA, Trenas A, Padilla-Leiva C et al.
Source URL https://pubmed.ncbi.nlm.nih.gov/42963299/
